These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3972392)

  • 41. The effect of different blood components on exchange transfusion outcomes.
    Ghaemi S; Saneian H; Mo'ayedi B; Pourazar A
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S45-8. PubMed ID: 22768458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single versus double volume exchange transfusion in jaundiced newborn infants.
    Thayyil S; Milligan DW
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004592. PubMed ID: 17054210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new chart for indicating exchange transfusion in neonatal hyperbilirubinaemia.
    Rosta J; Békefi D
    Acta Paediatr Acad Sci Hung; 1971; 12(3):311-6. PubMed ID: 5148793
    [No Abstract]   [Full Text] [Related]  

  • 44. The spectrum of ABO hemolytic disease of the newborn infant.
    Desjardins L; Blajchman MA; Chintu C; Gent M; Zipursky A
    J Pediatr; 1979 Sep; 95(3):447-9. PubMed ID: 469673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of measuring cord blood bilirubin concentration in ABO incompatibility.
    Haque KN
    Br Med J; 1978 Dec; 2(6152):1604. PubMed ID: 569526
    [No Abstract]   [Full Text] [Related]  

  • 46. [Value of immunologic tests in the hemolytic disease of the newborn in ABO incompatibility].
    Kourteva B; Doitchinova N; Chinkov D
    Nouv Rev Fr Hematol; 1968; 8(6):892-4. PubMed ID: 4236876
    [No Abstract]   [Full Text] [Related]  

  • 47. ABO system incompatibility: evaluation of risk of hyperbilirubinaemia at birth by multivariate discriminant analysis.
    Orzalesi M; Gloria-Bottini F; Lucarelli P; Lucarini N; Carapella E; Bottini E
    Experientia; 1983 Jan; 39(1):89-91. PubMed ID: 6825785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic significance of the determination of bilirubin fractions in the hemolytic disease of newborns].
    Hodr R; Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(1):21-7. PubMed ID: 5239111
    [No Abstract]   [Full Text] [Related]  

  • 49. Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility.
    Sisson TR; Kendall N; Glauser SC; Knutson S; Bunyaviroch E
    J Pediatr; 1971 Dec; 79(6):904-10. PubMed ID: 5132302
    [No Abstract]   [Full Text] [Related]  

  • 50. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABO incompatibility and neonatal hyperbilirubinemia.
    Chen SH; Lin KS; Chen CL
    Taiwan Yi Xue Hui Za Zhi; 1985 Nov; 84(11):1233-9. PubMed ID: 3868698
    [No Abstract]   [Full Text] [Related]  

  • 52. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
    Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations in the management of neonatal hyperbilirubinemia: impact on our understanding of fetal and neonatal physiology.
    Brown AK
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):22-30. PubMed ID: 5522330
    [No Abstract]   [Full Text] [Related]  

  • 55. [Icterus of the newborn].
    Krabisch H
    Zentralbl Gynakol; 1967 Dec; 89(52):1911-6. PubMed ID: 4969944
    [No Abstract]   [Full Text] [Related]  

  • 56. ABO INCOMPATIBILITY IN THE NEWBORN: A REVIEW OF CASES AND CURRENT CONCEPTS.
    MITCHELL JR
    J Iowa Med Soc; 1964 May; 54():235-8. PubMed ID: 14143966
    [No Abstract]   [Full Text] [Related]  

  • 57. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fototherapy of neonatal hyperbilirubinemia. Results of its clinical application (author's transl)].
    Hohenauer L; Haschke F; Gerstl JW
    Klin Padiatr; 1976 Jul; 188(4):314-9. PubMed ID: 988423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical analysis of seven cases of rare hemolytic disease of the newborn].
    Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.